cro quality benchmarking – phase ii/iii service providers (8th edition)

11
CRO QUALITY BENCHMARKING – PHASE II/III SERVICE PROVIDERS (8th EDITION) MARCH, 2016 PREVIEW OF

Upload: industry-standard-research

Post on 12-Apr-2017

107 views

Category:

Healthcare


1 download

TRANSCRIPT

Page 1: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

CRO QUALITY BENCHMARKING – PHASE II/III SERVICE PROVIDERS (8th EDITION)

M A R C H , 2 0 1 6

P R E V I E W O F

Page 2: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

REPORT OVERVIEW

HOW YOU CAN USE THIS REPORT

ISR’s “CRO Quality Benchmarking – Phase II/III Service Providers” report provides pharmaceutical sponsors and service providers a Consumer Reports-style analysis of CRO quality. Respondents supplied performance ratings based on their own experiences with 44 Phase II/III CROs, making this report the most comprehensive assessment of CRO service quality in the industry. Now in its 8th year, this report has become a crucial tool for sponsors looking to select a Phase II/III CRO and for service providers seeking an experience-based evaluation of their strengths and weaknesses.

D A T A C O L L E C T I O N

I N Q 3 - 4 , 2 0 1 5

3 0 - M I N U T E W E B - B A S E D

S U R V E Y

2 7 1 R E S P O N D E N T S F R O M U S , E U R O P E ,

A N D A S I A

179 PAGES

44 COMPANIES

VALUABLE FOR

MAJOR SECTIONS:1. Service Provider Selection

Process

2. Service Provider Perceptions and Interactions

3. Service Provider Performance and Loyalty

4. Company Service Quality Profiles

5. Study DataFOR PHARMA FOR CROSMake a more informed purchase of Phase II/III CRO services by understanding which service providers best fit your company’s needs.

Uncover your perceived strengths and weaknesses based on customer reviews, and compare your services to those of your competitors.

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

Full list of companies included on next page.

STUDY SPONSORS• Make a more informed purchase of Phase II/III services

by understanding which service providers best fit your company’s needs

• Broaden your Phase II/III CRO evaluation list by accessing peer-based service quality ratings across 26 critical attributes

• Pinpoint potential delivery concerns early in a sponsor-CRO relationship/ evaluation in order to develop proactive strategies to address potential gaps

CLINICAL SERVICE PROVIDERS• Uncover your own — and competitor — delivery strengths

and weaknesses• Design messaging to tout your company’s strengths• Compete more effectively by understanding buyers’

selection criteria and outsourcing trends

CLINICAL OPERATIONS

OUTSOURCING

SERVICE PROVIDER MARKETING

BUSINESS DEVELOPMENT

Page 3: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

COMPANIES INCLUDED

ATTRIBUTES MEASURED

Accell

Accelovance

Accenture

BioClinica

Bioskin

Chiltern

Clinical Research Services (CRS)

Clinipace

Clinlogix

Clinsys

Cognizant

Covance

DaVita Clinical Research

DCRI - Duke

Encorium

Eurofins

Eurotrials

Frontage

ICON

Inamed

INC Research

inVentiv Health Clinical

KCR

Lambda

Medpace

Medsource

NAMSA

Novotech

PAREXEL

Pharm-Olam International

PPD

PRA

Premier Research

ProTrials

QPS

Quintiles

Rho

SGS Life Sciences

Symbio

SynteractHCR

Tata

Theorem

TKL Research

Worldwide Clinical Trials

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

BUDGET FACTORS • Low cost• Minimizing change orders

DELIVERY FACTORS• Commercial market knowledge• Data quality• Easy to work with• Local market / Regulatory knowledge• Network of sites / investigators • Offered innovative solutions• Patient recruitment strategy• Technology for real-time access to

data• Up-front contingency planning and

trial risk management

ORGANIZATION FACTORS• Breadth of services• Financial strength / stability• Global footprint• Operational excellence

STAFF CHARACTERISTICS• CRA quality• Project manager quality• Project team chemistry• Responsiveness• Staff turnover• Study design expertise• Therapeutic expertise • Timely project communications

TIMELINES MANAGEMENT• Meeting overall project timelines• Speed of site / investigator

recruitment• Speed of site start-up

each company is evaluated

based on 26 CRITICAL ATTRIBUTES

data are included for all 44 CROs,

but companies with more

than 10 performance evaluations

(bold) receive a full profile

Companies listed bold have been reviewed by 10 or more respondents. These providers have in-depth performance analysis.

Page 4: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

TABLE OF CONTENTS

FOR FULL TABLE OF CONTENTS, PLEASE DOWNLOAD THE FULL PREVIEW AT:

HTTPS://WWW.ISRREPORTS.COM/REPORTS/CRO-QUALITY-BENCHMARKING-PHASE-IIIII-SERVICE-PROVIDERS-8TH-EDITION/

Page 5: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

SERVICE PROVIDER PERFORMANCE AND LOYALTY

CRO Quality Benchmarking – Phase II/III Service Providers (8th edition) 29www.ISRreports.com ©2016

Figure 14 - Customer Loyalty: 3 Year Rolling AverageISR also looks at the 3 year rolling average for loyalty scores to understand whether there are differences in longer term scores compared to scores for only this year’s data� In the case of the Phase II/III marketplace, the loyalty scores for this year are very consistent with the 3 year rolling averages� Chiltern, SGS Life Sciences, Quintiles, and Medpace are at the top while Cognizant, Premier Research, and Accenture are at the bottom�

This is an analysis of service provider performance for those with 20 or more respondents rating over the past 3 years�

CROQUALITYBENCHMARKING–PHASEII/IIISERVICEPROVIDERS(8THEDITION) 32

Figure 14 - Customer Loyalty: 3 Year Rolling Average ISR also looks at the 3 year rolling average for loyalty scores to understand whether there are differences in longer term scores compared to scores for only this year’s data. In the case of the Phase II/III marketplace, the loyalty scores for this year are very consistent with the 3 year rolling averages. Chiltern, SGS Life Sciences, Quintiles, and Medpace are at the top while Cognizant, Premier Research, and Accenture are at the bottom. This is an analysis of service provider performance for those with 20 or more respondents rating over the past 3 years.

4.9

5.6

5.7

5.8

5.9

6.4

6.4

6.4

6.5

6.5

6.6

6.6

6.6

6.7

6.8

6.9

7.0

7.0

7.1

7.3

1 2 3 4 5 6 7 8 9 10

Cognizant (n=36)

Premier Research (n=35)

Theorem (n=35)

Accenture (n=38)

INC Research (n=113)

PRA (n=127)

inVentiv Health Clinical (n=113)

ICON (n=179)

Tata (n=26)

Worldwide Clinical Trials (n=44)

BioClinica (n=33)

Industry Average

PAREXEL (n=236)

DCRI-Duke (n=40)

Covance (n=208)

PPD (n=196)

Medpace (n=38)

Quintiles (n=301)

SGS Life Sciences (n=33)

Chiltern (n=41)

Loyalty Score

© Industry Standard Research

S A M P L E P A G E :

CUSTOMER LOYALTYISR computes loyalty as an index that consists of Overall Satisfaction, Willingness to Recommend, and Likelihood to Use Again. ISR also looks at the 3 year rolling average for loyalty scores to understand whether there are differences in longer term scores compared to scores for only this year’s data.

The full data are available in the report, which can be downloaded from www.ISRreports.com.

CROQUALITYBENCHMARKING–PHASEII/IIISERVICEPROVIDERS(8THEDITION) 32

Figure 14 - Customer Loyalty: 3 Year Rolling Average ISR also looks at the 3 year rolling average for loyalty scores to understand whether there are differences in longer term scores compared to scores for only this year’s data. In the case of the Phase II/III marketplace, the loyalty scores for this year are very consistent with the 3 year rolling averages. Chiltern, SGS Life Sciences, Quintiles, and Medpace are at the top while Cognizant, Premier Research, and Accenture are at the bottom. This is an analysis of service provider performance for those with 20 or more respondents rating over the past 3 years.

6.5

5.7

6.5

7.1

7.0

5.6

6.4

6.9

6.6

7.0

6.4

6.6

5.9

6.4

6.7

6.8

4.9

7.3

6.6

5.8

1 2 3 4 5 6 7 8 9 10

Worldwide Clinical Trials (n=44)

Theorem (n=35)

Tata (n=26)

SGS Life Sciences (n=33)

Quintiles (n=301)

Premier Research (n=35)

PRA (n=127)

PPD (n=196)

PAREXEL (n=236)

Medpace (n=38)

inVentiv Health Clinical (n=113)

Industry Average

INC Research (n=113)

ICON (n=179)

DCRI-Duke (n=40)

Covance (n=208)

Cognizant (n=36)

Chiltern (n=41)

BioClinica (n=33)

Accenture (n=38)

Loyalty Score

D A T A I N F U L L R E P O R T

Page 6: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

SERVICE PROVIDER PERFORMANCE AND LOYALTY

CRO Quality Benchmarking – Phase II/III Service Providers (8th edition) 26www.ISRreports.com ©2016

Figure 11 - Staff Characteristics

Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency

Accenture

BioClinica

Chiltern

Cognizant

Covance

DCRI-Duke

Eurofins

ICON

INC Research

inVentiv Health Clinical

Medpace

PAREXEL

PPD

PRA

Premier Research

Quintiles

SGS Life Sciences

SynteractHCR

Tata

Theorem

Worldwide Clinical Trials

CRA quality

Project manager quality

Project team

chemistry ResponsivenessSta�

turnover

Study design

expertiseTherapeutic

expertiseTimely project

communications

© Industry Standard Research

S A M P L E P A G E :

SERVICE PROVIDER PERFORMANCEPart of the “Service Provider Performance and Loyalty” section, ISR provides an analysis of profiled companies’ service attribute ratings. This chart shows staff characteristics, but the report also includes ratings for: budget factors, delivery factors, organization factors, and timelines management.

The full data are available in the report, which can be downloaded from www.ISRreports.com.

Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency

Company A

Company B

Company C

Company D

Company E

Company F

Company G

Company H

Company I

Company J

Company K

Company L

Company M

Company N

Company O

Company P

Company Q

Company R

Company S

Company T

Company U

CRA quality

Project manager quality

Project team

chemistry ResponsivenessSta�

turnover

Study design

expertiseTherapeutic

expertiseTimely project

communications

Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency

Company A

Company B

Company C

Company D

Company E

Company F

Company G

Company H

Company I

Company J

Company K

Company L

Company M

Company N

Company O

Company P

Company Q

Company R

Company S

Company T

Company U

CRA quality

Project manager quality

Project team

chemistry ResponsivenessSta�

turnover

Study design

expertiseTherapeutic

expertiseTimely project

communications

D A T A H A V E B E E N R A N D O M I Z E D . F U L L C H A R T A V A I L A B L E I N T H E R E P O R T .

Page 7: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

S A M P L E P A G E : PHASE II/III COMPANY PROFILE

The Average Customer Experience section measures each company’s performance relative to expectations in each of the 26 attributes measured. For a list of attributes, refer to page three of this preview.

The Highlights section shows each company’s highest and lowest attributes, ranked by actual users.

The Customer Loyalty section measures overall satisfaction, likelihood to recommend, and likelihood to use again, compared to the industry average.

The Brand Snapshot section profiles awareness, familiarity, leadership, and use.

Companies with over 10 respondents are profiled.

Introduction

COMPANY SERVICE QUALITY PROFILES

CRO Quality Benchmarking – Phase II/III Service Providers (8th edition) 52www.ISRreports.com ©2016

BRAND SNAPSHOT

CUSTOMER LOYALTY

AVERAGE CUSTOMER EXPERIENCE

WORLDWIDE CLINICAL TRIALS

TOP 3 ATTRIBUTES:CRA quality

Easy to work with

Project manager quality

BOTTOM 3 ATTRIBUTES:Low cost

Minimizing change orders

Offered innovative solutions

HIGHLIGHTS

AWARENESS 63%

FAMILIARITY 39%

USE 8%

LEADERSHIP 3%

(N=18)

© Industry Standard Research

The Harvey Balls show each profiled provider’s rating across the ten most important attributes, relative to customer expectations�

This chart shows the profiled provider’s 2016 Customer Loyalty score in comparison to the 2016 industry average�

Therapeutic expertise

Patient recruitment strategy

Meeting overall project timelines

Data quality

Easy to work with Project manager quality

Global footprint Low cost Responsiveness

Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency

Operational excellence

INDUSTRY AVERAGE

WORLDWIDE CLINICAL TRIALS

6.7

6.7

SAMPLE COMPANY (N=45)

SAMPLE COMPANY

Page 8: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

FOR ADDITIONAL SAMPLE PAGES, PLEASE DOWNLOAD THE FULL PREVIEW AT:

HTTPS://WWW.ISRREPORTS.COM/REPORTS/CRO-QUALITY-BENCHMARKING-PHASE-IIIII-SERVICE-PROVIDERS-8TH-EDITION/

Page 9: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

ORDERING INFORMATION

Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services industries.  With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.   For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at www.ISRreports.com, email [email protected], or follow us on twitter @ISRreports.

ABOUT INDUSTRY STANDARD RESEARCH

>> R E G I S T E R N O W>>Receive $250 instant credit towards any ISR report

>>Earn 10% credit towards all future purchases

>>Receive advanced notifications on ISR’s latest reports and free resources

SAVE ON THIS, OR ANY ISR REPORT, BY CREATING A FREE ACCOUNT

FOR PRICING AND ORDERING INFORMATION, PLEASE DOWNLOAD THE FULL PREVIEW AT:

HTTPS://WWW.ISRREPORTS.COM/REPORTS/CRO-QUALITY-BENCHMARKING-PHASE-IIIII-SERVICE-PROVIDERS-8TH-EDITION/

Page 10: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

TO LEARN MORE: CONTACT US AT [email protected] OR +1(919)301-0106

Biosimilars & Biologics

Clinical Trial Recruitment &

Retention

Commercialization Department Models & Structures

Trends & Technologies

Manufacturing Service Provider Quality Benchmarking

CUSTOM RESEARCH

UNDERSTAND YOUR MARKETSLeverage ISR’s experience and institutional knowledge to create a fit-for-purpose market research project that addresses the business decisions you need to make.

Are you:• Developing a new product or service?• Evaluating a new market?• Targeting a new customer segment?• Entering a new geography?• Needing a deeper understanding of your

customer or potential customer base?

UNDERSTAND YOUR CUSTOMERSWho makes the decisions and in what contexts? ISR can help you gain a deeper understanding of your customers’ decision-making units (DMUs) and decision-making processes (DMPs).

Key Questions Addressed:• What motivates the purchase decision?• How are companies, products, solutions, and/or

brands evaluated?• What factors drive the final buying decision?• Where are your customers won or lost in the

purchasing process?• Why were specific opportunities won or lost?• How do you keep customers engaged and

manage their loyalty over time?

CUSTOM RESEARCH SERVICES• Investigator Forum• Brand, Advertising, and Message Testing• Loyalty Management• New Product and Service Development• Competitive Intelligence• Strategy War Games• MORE

S O M E T H I N G T O C O N S I D E R

DISTINCTIVE – Receive novel insights from industry decision-makers on topics including: service provider quality, patient recruitment, biosimilars, clinical technology, manufacturing, clinical operations, and commercial activities.

UNRESTRICTED – ISR doesn’t sell seats. Instantly obtain access for all employees within your organization

AFFORDABLE – Receive access to ALL reports in ISR’s library, as well as those released during your subscription period. ISR’s competitive library pricing equates to the cost of a few individual report purchases.

LIBRARY ACCESS SUBSCRIPTIONISR’s library access subscription provides your entire organization access to our full library of syndicated market research reports (100+ titles) plus access to all reports (~25 per year) released during your subscription period. Our research categories include:

Page 11: CRO Quality Benchmarking – Phase II/III  Service Providers   (8th EDITION)

Introduction

SMARTER QUESTIONS SMARTER ANSWERS

www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 11

act with confidence

www.ISRreports.com ©2015 | Preview of: Epithelial Ovarian Cancer: Disease and Pipeline Analysis 10

act with confidence

www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10

act with confidence

www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10

act with confidence

www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 10

act with confidence

The ISR DifferenceCustom-quality syndicated market research

www.ISRreports.com

ISR's Reports The Common Syndicated Reportvs.

How confident are you?

vs.Data Collection

ISR's proprietary data collection tools and channels support fast,

high quality data collection

Struggle to recruit the right targets and enough of them

vs.Sample Sizes

Robust sample sizes that instill confidence

Often insufficient industry representation that leaves you

defending results

vs.vs.Research methods

Mostly primary research;

always appropriate for the topic

One size fits all; usually publically

available data

vs.vs.Respondents

Sophisticated screening ensures genuine decision-makers

Undisclosed methodologies and

respondent demographics

vs.vs.Analysts

Decades of experience means more insights that are

immediately usable

Junior analysts capable of reporting numbers